Risk Factors Analysis of Cutaneous Adverse Drug Reactions Caused by Targeted Therapy and Immunotherapy Drugs for Oncology and Establishment of a Prediction Model
ABSTRACT Targeted therapy and immunotherapy drugs for oncology have greater efficacy and tolerability than cytotoxic chemotherapeutic drugs. However, the cutaneous adverse drug reactions associated with these newer therapies are more common and remain poorly predicted. An effective prediction model...
Saved in:
| Main Authors: | Zimin Zhang, Mingyang Zhu, Weiwei Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/cts.70118 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program
by: Tinashe Mudzviti, et al.
Published: (2012-11-01) -
Cutaneous adverse drug reactions and their impact on the quality of life of patients: a study at a tertiary care centre
by: Shivani, et al.
Published: (2025-07-01) -
Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting
by: Emma L. Myers, BA, et al.
Published: (2025-04-01) -
Cutaneous Adverse Drug Reactions in a Tertiary Care Hospital: A Record-based Observational Study
by: Rupak Chatterjee, et al.
Published: (2024-07-01) -
Immuno-oncological drugs application in the treatment of metastatic cutaneous melanoma with lymph nodes metastases of rare localization: a case report
by: A. P. Polyakov, et al.
Published: (2022-04-01)